» Articles » PMID: 24322275

Specific MAIT Cell Behaviour Among Innate-like T Lymphocytes in Critically Ill Patients with Severe Infections

Overview
Specialty Critical Care
Date 2013 Dec 11
PMID 24322275
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: In between innate and adaptive immunity, the recently identified innate-like mucosal-associated invariant T (MAIT) lymphocytes display specific reactivity to non-streptococcal bacteria. Whether they are involved in bacterial sepsis has not been investigated. We aimed to assess the number and the time course of circulating innate-like T lymphocytes (MAIT, NKT and γδ T cells) in critically ill septic and non-septic patients and to establish correlations with the further development of intensive care unit (ICU)-acquired infections.

Methods: We prospectively enrolled consecutive patients with severe sepsis and septic shock. Controls were critically ill patients with non-septic shock and age-matched healthy subjects. Circulating innate-like lymphocytes were enumerated using a flow cytometry assay at day 1, 4 and 7.

Results: One hundred and fifty six patients (113 severe bacterial infections, 36 non-infected patients and 7 patients with severe viral infections) and 26 healthy subjects were enrolled into the study. Patients with severe bacterial infections displayed an early decrease in MAIT cell count [median 1.3/mm(3); interquartile range (0.4-3.2)] as compared to control healthy subjects [31.1/mm(3) (12.1-45.2)], but also to non-infected critically ill patients [4.3/mm(3) (1.4-13.2)] (P < 0.0001 for all comparisons). In contrast NKT and γδ T cell counts did not differ between patients groups. The multivariate analysis identified non-streptococcal bacterial infection as an independent determinant of decrease in MAIT cell count. Furthermore, the incidence of ICU-acquired infections was higher in patients with persistent MAIT cell depletion.

Conclusions: This large human study provides valuable information about MAIT cells in severe bacterial infections. The persistent depletion of MAIT cells is associated with the further development of ICU-acquired infections.

Citing Articles

Distinct MAIT cell phenotypes associated with sepsis clinical outcome in emergency department patients.

Emgard J, Filipovic I, Unge C, Palma Medina L, Parke A, Bergsten H Clin Transl Immunology. 2025; 14(3):e70028.

PMID: 40041474 PMC: 11879382. DOI: 10.1002/cti2.70028.


Macrophage activation syndrome in Sepsis: from pathogenesis to clinical management.

Chen S, Zhang C, Luo J, Lin Z, Chang T, Dong L Inflamm Res. 2024; 73(12):2179-2197.

PMID: 39404874 DOI: 10.1007/s00011-024-01957-7.


Lymphopenia in sepsis: a narrative review.

Wang Z, Zhang W, Chen L, Lu X, Tu Y Crit Care. 2024; 28(1):315.

PMID: 39304908 PMC: 11414153. DOI: 10.1186/s13054-024-05099-4.


Innate immune response in acute critical illness: a narrative review.

Stiel L, Gaudet A, Thietart S, Vallet H, Bastard P, Voiriot G Ann Intensive Care. 2024; 14(1):137.

PMID: 39227416 PMC: 11371990. DOI: 10.1186/s13613-024-01355-6.


Phenotype and function of MAIT cells in patients with alveolar echinococcosis.

Li J, Zhao H, Lv G, Aimulajiang K, Li L, Lin R Front Immunol. 2024; 15:1343567.

PMID: 38550591 PMC: 10973110. DOI: 10.3389/fimmu.2024.1343567.


References
1.
Treiner E, Lantz O . CD1d- and MR1-restricted invariant T cells: of mice and men. Curr Opin Immunol. 2006; 18(5):519-26. DOI: 10.1016/j.coi.2006.07.001. View

2.
Bendelac A, Bonneville M, Kearney J . Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol. 2002; 1(3):177-86. DOI: 10.1038/35105052. View

3.
Bonneville M, Scotet E . Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors. Curr Opin Immunol. 2006; 18(5):539-46. DOI: 10.1016/j.coi.2006.07.002. View

4.
Kawachi I, Maldonado J, Strader C, Gilfillan S . MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response. J Immunol. 2006; 176(3):1618-27. DOI: 10.4049/jimmunol.176.3.1618. View

5.
Croxford J, Miyake S, Huang Y, Shimamura M, Yamamura T . Invariant V(alpha)19i T cells regulate autoimmune inflammation. Nat Immunol. 2006; 7(9):987-94. DOI: 10.1038/ni1370. View